ロード中...
Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer
BACKGROUND: Delays in the initiation of therapy among patients with early stage breast cancer (BC) can negatively affect outcomes. Patients treated with neoadjuvant systemic chemotherapy (NSC) usually display tumors with high‐risk features. Considering these high‐risk characteristics and the evidenc...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485349/ https://ncbi.nlm.nih.gov/pubmed/32431013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0744 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|